Gamma Delta Lymphocytes in Endocrine Autoimmunity: Evidence of Expansion in Graves' Disease but Not in Type 1 Diabetes
Overview
Affiliations
Endocrine autoimmune disorders are mediated by T cell-dependent responses to organ-specific antigens, but the mechanisms initiating the process remain unknown. Lymphocytes which use the gamma delta heterodimer as T cell receptor (TCR) for antigen constitute a distinct subset of T cells whose function remains elusive. In order to investigate their possible involvement in endocrine autoimmunity we have determined the proportion of gamma delta T cells in the peripheral blood of 23 patients with type 1 (insulin-dependent) diabetes mellitus (type-1 DM) and 30 patients with autoimmune thyrotoxicosis (Graves' disease). T lymphocyte TCR expression was assessed by fluorescence-activated flow cytometry on peripheral blood mononuclear cells using MoAbs UCHT1 (CD3), TCR delta 1 (gamma delta TCR), WT31 and beta F1 (alpha beta TCR) and both the percentage of T cells expressing gamma delta and the ratio gamma delta/alpha beta were calculated. In the diabetic patients gamma delta cells were not significantly different from the control group (7.7 +/- 54% versus 8.0 +/- 5.5% of T cells, P NS). There was no relation between the proportion of gamma delta lymphocytes and the presence of islet cell antibodies (ICA) in the sera. The Graves' patients showed a tendency towards a higher proportion of gamma delta T lymphocytes than the controls (gamma delta/alpha beta ratios: 0.095 +/- 0.047 versus 0.063 +/- 0.022, P = 0.03). In 14 Graves' patients the number of gamma delta were measured in paired samples of peripheral and intrathyroidal lymphocytes, demonstrating an expansion of gamma delta within the thyroid glands (0.21 +/- 0.3 versus 0.095 +/- 0.047, P = 0.032). Immunohistochemical studies showed that gamma delta cells were scattered among the predominant alpha beta lymphocytes infiltrating the thyroid gland and that they account for 10% of intraepithelial lymphocytes. No relation was found between the increase of gamma delta lymphocytes and any clinical features.
Gupta K, Estrella J, Rajagopal R, Shanmugalingam P, Simmons D Clin Case Rep. 2017; 5(8):1226-1229.
PMID: 28781829 PMC: 5538055. DOI: 10.1002/ccr3.1022.
Role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity.
Champagne E, Martinez L, Vantourout P, Collet X, Barbaras R Immunol Res. 2006; 33(3):241-55.
PMID: 16462001 DOI: 10.1385/ir:33:3:241.
Seagal J, Melamed D Immunology. 2004; 112(2):265-73.
PMID: 15147570 PMC: 1782487. DOI: 10.1111/j.1365-2567.2004.01883.x.
Triolo G, Accardo-Palumbo A, Dieli F, Ciccia F, Ferrante A, Giardina E Arthritis Res Ther. 2003; 5(5):R262-8.
PMID: 12932289 PMC: 193723. DOI: 10.1186/ar785.
Primary sclerosing cholangitis.
Mitchell S, Chapman R Clin Rev Allergy Immunol. 2000; 18(2):185-214.
PMID: 10944705 DOI: 10.1385/CRIAI:18:2:185.